Which pipeline therapy has the potential to revolutionize the Down Syndrome Market?
Oct 30, 2020
Everyone can think that extra add-ons to the living may change the lifestyles. Is the leverage similar in life with an extra-chromosome?? The answer is, No! Take the case o...
Read More
Novartis taps Molecular Partners to combat COVID-19; GSK culls phase 2 asthma drug; Exact Sciences acquires Thrive for $ 2.15 B; EQRx-CStone’s deal for checkpoint inhibitors
Oct 29, 2020
Novartis taps Molecular Partners for a novel approach to combat COVID-19 Novartis is spending USD 69 million upfront on a pair of experimental drugs from Molecular Partners...
Read More
How Will Artificial Intelligence Change The Future Of Healthcare?
Oct 28, 2020
Artificial intelligence (AI) is the talk of the town. Though the term AI and its uses are not new, however, in the past few years there has been a phenomenal growth in AI r...
Read More
Bayer eyes AskBio’s Gene Therapies; Novartis’ Iptacopan; Forma’s IDH1-Mutated AML Therapy; EpicGenetics teams up with Mayo Clinic
Oct 27, 2020
Bayer Set to Fork Over USD 4 Billion for AskBio’s Gene Therapies Germany-based Bayer is set to acquire North Carolina-based Asklepios BioPharmaceutical (AskBio) with moti...
Read More
7 Most Common Myths About Breast Cancer Demystified
Oct 26, 2020
Every year this month, a lot of campaigns take place to raise awareness about breast cancer, its symptoms, early diagnosis, and treatment options. Much progress has been ma...
Read More
Key Facts To Know About Triple-Negative Breast Cancer In The Breast Cancer Awareness Month
Oct 23, 2020
October, worldwide, is designated as the Breast cancer awareness month. Pink ribbons. Pink colored tee-shirts. Pink banners. Going pink, wearing pink – the whole mont...
Read More
GSK’s RSV vaccine; SparingVision’s interest in gene therapy; InCarda’s raise; BridgeBio’s R&D deal
Oct 22, 2020
GSK eyes robust immune response from RSV vaccine Cold viruses mostly do not get much attention in terms of R&D. They usually make humans feel miserable for a few days...
Read More
Adding Value to the Health with a Value-Based Healthcare Model
Oct 21, 2020
In today’s healthcare system quality care, rising cost, and satisfaction are significant issues that need to be addressed to improve the experience of patients. To provid...
Read More
Venclexta full approval; PBP1510 Orphan Status; Roche/ Genesis collab; Immunomodulators for COVID-19
Oct 20, 2020
Full FDA Approval for Venclexta Combinations for Acute Myeloid Leukemia The US FDA has granted its full approval to Venclexta (venetoclax) for newly diagnosed acute mye...
Read More
The Growing Burden Of Neurodegenerative Disorders
Oct 19, 2020
Neurodegenerative diseases affect millions of people worldwide. And with the world demographics getting older, it is apt to foretell that the burden of neurodegenerative di...
Read More
Breast Cancer: Understand your breasts, recognize the symptoms
Oct 16, 2020
Breast cancer is the most common form of cancer in women. Each year, it affects over 2 million women globally and is the most significant cause of death among women. The ep...
Read More
Cyclerion’s olinciguat flunks sickle cell test; Nimbus nets $60M; Dyno-Roche’s gene therapy pact; RayzeBio debuts with $ 45M to target tumors
Oct 15, 2020
Cyclerion flunks sickle cell test, prompting pivot to CNS disease Cyclerion Therapeutics has terminated the development of olinciguat in sickle cell disease after getting a...
Read More
Understanding The Disparities In The Healthcare Sector
Oct 15, 2020
The disparity can be any type of imbalance or inequality that brings various types of variation in society, based on age, education, income, gender, etc. In a society, a wi...
Read More
US/AZ deal; Alkermes’ Schizophrenia drug; Innovent/Lilly’s China market expansion; Rejection for Avenue
Oct 13, 2020
U.S., AstraZeneca strikes an antibody treatment USD 486 million deal The U.S. government awarded the pharma giant AstraZeneca a sum of USD 486 million for the development o...
Read More
Market Drivers and Barriers That Will Shape The NMIBC Market In The Next Ten Years
Oct 12, 2020
After 40 years of the introduction of the BCG immunotherapy, it continues to remain as the gold standard of the treatment of Non-muscle invasive bladder cancer (NMIBC). How...
Read More
